N-cyano-N'-(6-(o-chlorophenoxy)hexyl)-N"-(4-pyridyl)guanidine | 200484-22-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: N-cyano-N'-(6-(o-chlorophenoxy)hexyl)-N"-(4-pyridyl)guanidine
• 英文别名: 2-[6-(2-chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine
• CAS: 200484-22-6
• 化学式: C₁₉H₂₂ClN₅O
• 分子量: 371.87
• InChiKey: BOHZGHNXINCIBJ-UHFFFAOYSA-N

物化性质

• 沸点：
  530.3±58.0 °C(predicted)
• 密度：
  1.18±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  26
• 可旋转键数：
  11
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  82.3
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  4-氨基吡啶 在 吡啶 、 4-二甲氨基吡啶 、 sodium hydride 、 三乙胺 作用下， 以 N,N-二甲基甲酰胺 、 paraffin 为溶剂， 反应 11.0h， 生成 N-cyano-N'-(6-(o-chlorophenoxy)hexyl)-N"-(4-pyridyl)guanidine
  参考文献：
  名称：

  Novel cyanoguanidines with potent oral antitumour activity

  摘要：

  4-Pyridyl cyanoguanidines with hydrophobic aromatic side chains showed potent antiproliferative activity in the human breast and lung cancer cell lines MCF-7, NYH and H460. In vivo, treatment with N-(6-chlorophenoxyhexyl)-N'-cyano-N "-4-pyridylguanidine (18, 20 mg/kg/day po.), gave a complete remission of tumours in a model of NYH inoculated nude mice. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(97)10152-4

文献信息

• PYRIDYL CYANOGUANIDINE DERIVATIVES
  申请人：Zhang Hesheng

  公开号：US20120309797A1

  公开（公告）日：2012-12-06

  Compounds of formula (I) or pharmaceutically acceptable salts thereof, and use for treating cancer thereof are disclosed, wherein, the definitions of X, Y, R 1 , R 2 and n are described in description.

  公式（I）的化合物或其药用盐的使用，以及用于治疗癌症的方法已被披露，其中，X、Y、R1、R2和n的定义在描述中描述。
• PHARMACEUTICAL COMPOSITIONS CONTAINING PYRIDYL CYANOGUANIDINES, PREPARATION METHODS AND USES THEREOF
  申请人：Tianjin Hemay Bio-Tech Co., Ltd.

  公开号：EP2394649A1

  公开（公告）日：2011-12-14

  The compositions formed from pyridyl cyanoguanidines and cyclodextrins, cyclodextrin derivatives and/or surfactants with solubilization, preparation methods and uses thereof.

  由吡啶基氰基胍和环糊精、环糊精衍生物和/或表面活性剂形成的组合物及其溶解、制备方法和用途。
• PHARMACEUTICAL COMPOSITIONS COMPRISING PYRIDYL CYANOGUANIDINE, PROCESS FOR PREPARING THE SAME AND USE THEREOF
  申请人：Zhang Hesheng

  公开号：US20120029036A1

  公开（公告）日：2012-02-02

  Disclosed are a composition comprising a pyridyl cyanoguanidine and a cyclodextrin, a cyclodextrin derivative and/or a surfactant with solubilization, process for preparing the same and use thereof.
• NMN MODULATORS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
  申请人：Coleman Michael

  公开号：US20130131111A1

  公开（公告）日：2013-05-23

  The invention relates to a nicotinamide mononucleotide (NMN) modulator useful as a neuroprotective medicament in the treatment of neurodegenerative disorders, in particular but not exclusively disorders involving axon degeneration of neuronal tissue such as Wallerian degeneration, to the use of NMN as a biomarker for axon degeneration, to a method of demonstrating axon degeneration using an NMN-based biomarker, to a diagnostic kit for detecting axon degeneration, to a method of screening for an NMN modulator, and to an NMN modulator identified using the aforementioned screening method.
• US5696140A
  申请人：——

  公开号：US5696140A

  公开（公告）日：1997-12-09